We reviewed the options for the manufacture and use of DNA microarrays in the original Chipping Forecast 1 in 1999. Since then, the number of companies that produce microarrays equipment and reagents ...

The phase 1/2 randomized trial compared results from the measles and rubella vaccine delivered by a microarray patch, a small sticking plaster-like device with an array of microscopic projections that ...

A Phase I/II randomized trial compared results from the measles and rubella vaccine delivered by a microarray patch, a small sticking plaster-like device with an array of microscopic projections that ...

More and more scientists are taking advantage of DNA microarray chip technology to further their research. PubMed can give a rough estimate of the growth and acceptance of this technology; a search ...

A survey of scientists developing bioprocesses found efficiency to be the top concern, with pressure growing each year to “produce more, do it more quickly, and do so with fewer resources.” 1 Yet, ...

The first study of the use of microarray patches to vaccinate children has shown that the method is safe and induces strong immune responses. The phase 1/2 randomized trial compared results from the ...

In several fields including environmental monitoring, food manufacturing, and biomedical research, the ability to perform accurate measurements is key to a variety of studies. Whilst it is sufficient ...

Thermo Fisher Scientific, Inc. TMO recently launched the Applied Biosystems CytoScan HD Accel array — a new chromosomal microarray intended to enhance cytogenetic research lab productivity, efficiency ...

Microarray Scanners are devices used to measure the fluorescent areas of a DNA microarray to reveal information about the simultaneous activity of thousands of genes. This information can help ...

Microarray technology has the unparalleled potential to simultaneously determine the dynamics and/or activities of most, if not all, of the microbial populations in complex environments such as soils ...

The research community's rapid acceptance of microarrays notwithstanding, technical challenges remain. Biochip developers continue to grapple with these issues while upgrading their offerings and ...

JA Rosenfeld is an employee of Signature Genomic Laboratories, a subsidiary of PerkinElmer, Inc. The authors have no other relevant affiliations or financial involvement with any organization or ...